The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoldPlat Regulatory News (GDP)

Share Price Information for GoldPlat (GDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 7.80
Ask: 8.50
Change: -0.15 (-1.94%)
Spread: 0.70 (8.974%)
Open: 7.75
High: 7.60
Low: 7.60
Prev. Close: 7.75
GDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Preliminary Results & Sale of Kilimapesa

11 Nov 2020 12:51

RNS Number : 0101F
Goldplat plc
11 November 2020
 

Goldplat plc / Ticker: GDP / Index: AIM / Sector: Mining & Exploration

 

 

11 November 2020

 

Goldplat plc

('Goldplat', the 'Group' or 'the Company')

 

Update on timing of the preliminary results announcement for 30 June 2020 and the sale of Kilimapesa

 

 

Goldplat plc (“Goldplat”), the AIM quoted gold producer, with international gold recovery operations located in South Africa and Ghana and an held for sale mining operation in Kenya, is pleased to provide an update on the publication of its preliminary results for the year ended 30 June 2020.

 

The preliminary results announcement is in the process of finalisation and will be released towards the end of November 2020 and will include restated results for the prior year. These restatements do not have a cashflow impact and result in a modest net increase in equity attributable to Goldplat shareholders. The accounts will show the results for the prior year restated for:

 

· The allocation the attributable portion of the translation loss to the minority shareholders' non-controlling interest reserve. The translation loss arose on the conversion of the Goldplat Recovery (Pty) limited ("GPL") results to sterling during the prior year.

· The recognition of the environmental and decommissioning assets for GPL and Kilimapesa which should be amortised over the life of the asset. The environmental liabilities were adequately provided for in prior years and expensed as rehabilitation costs, without raising a corresponding asset. A decommissioning asset should have been raised and then amortised over the life of the operations.

· On 5 November 2018, Ashanti Gold Corp Limited (Ashanti") exercised its option to earn a 51% shareholding in Anumso, after expending USD 1 500 000 on exploration. Additional shares were not issued to Ashanti at that time and Ashanti did not appoint any board members. A decision was made to consolidate the Anumso results as at 30 June 2019, as Ashanti were not seen to have legal control. However, because Ashanti did take over effective control of Anumso in the prior year, we have restated the prior results and have accounted for Anumso on an equity accounting basis. As part of the restatement, the translation loss relating to Anumso will be allocated to retained earnings through the statement of profit and loss.

Kilimapesa Update

Progress has been made on the transaction with a draft restructuring plan and due diligence information received from Mayflower and we are working closely with them in advancing the transaction and finalising the due diligence, which will only be completed once the restructuring plan has been concluded. Further to the Company's announcement of 15 October 2020, it has been agreed that all conditions have been met or waived and the exclusivity period for the sale of Kilimapesa be extended to 31 December 2020. Further updates will be provided on the transaction in due course.

Werner Klingenberg, CEO of Goldplat commented: "I fully support these improvements in our reported results and despite the additional delay this has caused I trust it will be useful to all stakeholders involved. The progress made on the Kilimapesa transaction have been encouraging and we look forward to share updated timelines soon."

 

For further information visit www.goldplat.com, follow on Twitter @GoldPlatPlc or contact:

 

Werner Klingenberg

 

Goldplat plc

(CEO)

 

Tel: +27 (0) 82 051 1071

Colin Aaronson / Harrison Clarke/Seamus Fricker

 

Grant Thornton UK LLP

(Nominated Adviser)

Tel: +44 (0) 20 7383 5100

 

James Joyce / Jessica Cave

 

WH Ireland Limited

(Broker)

 

Tel: +44 (0) 207 220 1666

 

Tim Thompson / Mark Edwards / Fergus Mellon

Flagstaff Strategic and Investor Communications

Tel: +44 (0) 207 129 1474

goldplat@flagstaffcomms.com

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKKDBQBBDDNDD
Date   Source Headline
20th Aug 202112:48 pmRNSUpdate on Kilimapesa
6th Aug 20212:40 pmRNSExercise of Options and Total Voting Rights
5th Aug 20217:00 amRNSQuarterly Update - Update on 12 months 30 June 21
30th Jul 20217:00 amRNSTotal Voting Rights
23rd Jul 20212:57 pmRNSExercise of Options
20th Jul 20219:38 amRNSReplacement:Update on consideration for Kilimapesa
20th Jul 20217:08 amRNSUpdate on Consideration Receivable for Kilimapesa
20th Jul 20217:00 amRNSCorporate Transactions and Dividend Policy
19th Jul 20217:00 amRNSUpdate on consideration receivable for Kilimapesa
17th May 20217:00 amRNSUpdate on the nine months ended 31 March 2021
26th Apr 20217:00 amRNSCompletion of Sale of Kilimapesa Gold (Pty) Ltd
1st Apr 202110:00 amRNSUpdate on Sale of Kilimapesa
30th Mar 20217:00 amRNSResignation of Director
16th Mar 20211:18 pmRNSReplacement: Interim Results 31 Dec 20
12th Mar 20214:42 pmRNSInterim Results for the six months ended 31 Dec 21
11th Mar 20217:00 amRNSUpdate on sale of Kilimapesa
5th Mar 20217:00 amRNSInterim Results for the six months ended 31 Dec 20
2nd Mar 20217:00 amRNSUpdates on Group Structure and Interim Results
23rd Feb 20217:00 amRNSUpdate on sale of Kilimapesa
19th Feb 20218:24 amRNSUpdate on the Simplifying Group Structure
18th Feb 20217:38 amRNSUpdate on sale of Kilimapesa
15th Feb 20217:00 amRNSSimplifying Group Structure to Reduce Group Costs
8th Feb 20217:00 amRNSUpdate on six months ended 31 December 2020
22nd Jan 20217:00 amRNSLondon South East Investor Webinar
4th Jan 20218:45 amRNSUpdate on Sale of Kilimapesa
31st Dec 20201:23 pmRNSResult of AGM / Directorate Change
30th Dec 20207:15 amRNSNotice of Investor and Analyst Conference Call
9th Dec 20207:00 amRNSNotice of Investor and Analyst Conference Call
7th Dec 202011:46 amRNSPosting of Annual Report and Notice of AGM
30th Nov 20207:00 amRNSPreliminary Unaudited Results for YE 30 Jun 2020
11th Nov 202012:51 pmRNSUpdate on Preliminary Results & Sale of Kilimapesa
26th Oct 20207:17 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSQuarterly Update - Q1 Ended 30 Sept 2020
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:36 pmRNSPrice Monitoring Extension
15th Oct 20207:00 amRNSUpdate on preliminary results & Sale of Kilimapesa
1st Oct 20207:00 amRNSUpdate - Preliminary Results & Sale of Kilimapesa
18th Sep 20207:05 amRNSUpdate on sale of Kilimapesa Pty Limited
3rd Sep 20207:12 amRNSUpdate on the sale of Kilimapesa Pty Limited
26th Aug 20207:32 amRNSHolding(s) in Company
4th Aug 20208:16 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSSigning of term sheet for sale of Kilimapesa Gold
28th Jul 20207:00 amRNSQuarterly Operational Update - Q4 30 June 2020
15th Jul 20204:16 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSExercise of Options
26th Jun 202012:57 pmRNSDirector/PDMR Shareholding
21st May 202010:03 amRNSHolding(s) in Company
14th May 202010:47 amRNSAppointment of Non-executive Director
28th Apr 20208:53 amRNSQuarterly Operational Update - Q3 31 March 2020
17th Apr 202011:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.